UK cardiology market is estimated to grow significantly at a CAGR of around 6.4% during the forecast period. UK has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease that further contributing to the growth of the market. According to one of the reports published by the British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. The above data reflects the mortalities recorded in England, Wales, Scotland and Northern Ireland. A total of 56,493 mortalities were recorded in England followed by 7,182 in Scotland. Similarly, Wales and Northern Ireland reported 4,082 and 1,825 deaths respectively. These numbers of mortalities and incidence of heart related diseases increase the demand for cardiology devices, drugs and surgeries that further propels the market growth.
To Request a Sample of our Report on UK Cardiology Market: https://www.omrglobal.com/request-sample/uk-cardiology-market
The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.
(Get 15% Discount on Buying this Report)
A full Report of UK Cardiology Market is Available at: https://www.omrglobal.com/industry-reports/uk-cardiology-market
UK Cardiology Market Segmentation
By Device Type
- Angioplasty
- Cardiovascular stents
- Cardiovascular catheters
- Cardiac rhythm management
- Cardiovascular assistive devices
By Drug Type
- Antithrombotic drugs
- Antidyslipidemic drugs
- Antihypertensive drugs
- Anti-stroke drugs
By Mechanism
- Beta blockers
- Beta agonists
- Alpha blockers
- Alpha agonists
- Sodium channel blockers
- Calcium channel blockers
- Vasodilators
- Renin inhibitors
- Angiotensin receptor blockers
- Diuretics
- Thrombolytics
By Surgeries Type
- Coronary artery bypass grafting
- Transmyocardial laser revascularization
- Heart valve repair
- Arrhythmia treatment
- Aneurysm repair
- Heart transplant
Company Profiles
- Abbott Laboratories
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche AG
- General Electric Co.
- Medtronic PLC
- Merck KGaA
- Novartis International AG
- Sanofi S.A.
Reasons to Buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-cardiology-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
